What Improves Glycemic Control in Diabetes? Evidence-Based Strategies

Evidence on improving glycemic control

Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.

Build your Evidence Workspace

Save evidence about the topics you care about.

150

Studies

100

Evidence Pairs

Extensive Research

Evidence Base: 71/100

Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Glycemic Control evidence appears to center on Metformin.

Among 150 indexed studies and 65 interventions, the strongest signals are summarized from the available evidence. Insulin therapy has been studied often, while Metformin appears to have stronger current evidence signals.

Evidence is consistently positive across multiple studies.
Some evidence is positive, but results are not consistent across all studies.
Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: May 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Metformin appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies

Evidence basis: 19 evidence pairs - 32 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsGenerally consistent

Metformin

9 studies

EvidenceScore™

83/100

ConsistencyScore™

69/100

Hybrid closed-loop system

7 studies

EvidenceScore™

84/100

ConsistencyScore™

67/100

Evidence Snapshot

150

Studies

Interventions

Outcomes

Strong evidence signals

Mixed evidence areas

Evidence freshness

May 2026

Latest indexed

Key Findings

Key patterns and insights identified across the research landscape

Moderate positive signal

Hybrid closed-loop system may improve Time in range

Hybrid closed-loop system → Time in range

Across 7 studies, Hybrid closed-loop system shows a consistent moderate positive signal for Time in range.

7 studies

EvidenceScore™: 83.57142857142857/100

View supporting studies

Moderate positive signal

Continuous glucose monitoring may improve Time in range

Continuous glucose monitoring → Time in range

Across 6 studies, Continuous glucose monitoring shows a consistent moderate positive signal for Time in range.

6 studies

EvidenceScore™: 83.41025641025641/100

View supporting studies

Strong positive signal

Metformin shows strong evidence for improving Fasting Plasma Glucose (FPG)

Metformin → Fasting Plasma Glucose (FPG)

Across 5 studies, Metformin shows a consistent strong positive signal for Fasting Plasma Glucose (FPG).

5 studies

EvidenceScore™: 83.16923076923077/100

View supporting studies

Neutral signal

Usual care shows limited or neutral effect on Fasting Plasma Glucose (FPG)

Usual care → Fasting Plasma Glucose (FPG)

Across 4 studies, Usual care shows a consistent neutral signal for Fasting Plasma Glucose (FPG).

4 studies

EvidenceScore™: 79/100

View supporting studies

Evidence signal

Lifestyle intervention for prediabetes shows evidence for 2-hour plasma glucose

Lifestyle intervention for prediabetes → 2-hour plasma glucose

Across 3 studies, Lifestyle intervention for prediabetes shows a evidence signal for 2-hour plasma glucose.

3 studies

EvidenceScore™: 79/100

View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Insulin therapy is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Insulin therapy

Metformin

Insulin therapy

9 studies

EvidenceScore™

79/100

ConsistencyScore™

55/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results PresentNegative Results Present

Evidence basis: 20 evidence pairs - 36 studies

View supporting studies

Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Multi-species synbiotic (12 probiotic strains + FOS prebiotic) may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Multi-species synbiotic (12 probiotic strains + FOS prebiotic)

Dapagliflozin

Multi-species synbiotic (12 probiotic strains + FOS prebiotic)

3 studies

EvidenceScore™

79/100

ConsistencyScore™

63/100

Why this appears here

Positive effect signalLimited study volume

Evidence basis: 12 evidence pairs - 14 studies

View supporting studies

Question Highlights

Quick answers to the most important questions supported by the available evidence.

Explore all evidence questions

What improves glycemic control?

Continuous glucose monitoring, Metformin, and Multi-species synbiotic (12 probiotic strains + FOS prebiotic) are among the most studied approaches for Glycemic Control.

Hybrid closed-loop system, Continuous glucose monitoring, and Metformin are among the best-supported options in the available evidence across 150 studies.

The evidence includes both beneficial and harmful or worsening results.

View full answer

How can I lower blood glucose?

Continuous glucose monitoring, Metformin, and Multi-species synbiotic (12 probiotic strains + FOS prebiotic) are among the most studied approaches for Blood glucose.

Emerging evidence is based on 32 supporting studies.

Consistency cannot yet be determined.

View full answer

Continuous glucose monitoring vs Metformin for glycemic control?

Continuous glucose monitoring and Metformin have available evidence for Glycemic Control, but the comparison requires review of the underlying studies.

Evidence is available for both Continuous glucose monitoring and Metformin; the underlying studies are needed for a direct comparison.

The evidence includes both beneficial and harmful or worsening results.

View full answer

Explore all evidence questions

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Questions Answered by the Evidence

What improves glycemic control?

outcome achievement

Moderate Evidence

Continuous glucose monitoring, Metformin, and Multi-species synbiotic (12 probiotic strains + FOS prebiotic) are among the most studied approaches for Glycemic Control.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Hybrid closed-loop system
EvidenceScore™ Strong | EvidenceScore™ 83.6 | moderate positive | ConsistencyScore™ Consistent | 7 studies
2
Continuous glucose monitoring
EvidenceScore™ Strong | EvidenceScore™ 83.4 | moderate positive | ConsistencyScore™ Consistent | 6 studies
3
Metformin
EvidenceScore™ Strong | EvidenceScore™ 83.2 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

Does Continuous glucose monitoring improve glycemic control?

intervention effectiveness

Strong Evidence

Continuous glucose monitoring may improve Blood glucose.

ConsistencyScore™: Results are consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Continuous glucose monitoring
EvidenceScore™ Strong | EvidenceScore™ 83.4 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

Does Metformin improve glycemic control?

intervention effectiveness

Strong Evidence

Metformin may improve Blood glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

1
Metformin
EvidenceScore™ Strong | EvidenceScore™ 83.2 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Does Multi-species synbiotic (12 probiotic strains + FOS prebiotic) improve glycemic control?

intervention effectiveness

Strong Evidence

Multi-species synbiotic (12 probiotic strains + FOS prebiotic) may improve Blood glucose.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

1
Multi-species synbiotic (12 probiotic strains + FOS prebiotic)
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 3 studies

Why this answer: This answer is based on 3 supporting studies with generally consistent results and a positive effect signal.

Limitations

Population details are unavailable.

Continuous glucose monitoring vs Metformin for glycemic control?

compare

Strong Evidence

Continuous glucose monitoring and Metformin have available evidence for Glycemic Control, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Continuous glucose monitoring
EvidenceScore™ Strong | EvidenceScore™ 83.4 | moderate positive | ConsistencyScore™ Consistent | 6 studies
2
Metformin
EvidenceScore™ Strong | EvidenceScore™ 83.2 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

Population details are unavailable.

How can I lower blood glucose?

sub outcome

Emerging Evidence

Continuous glucose monitoring, Metformin, and Multi-species synbiotic (12 probiotic strains + FOS prebiotic) are among the most studied approaches for Blood glucose.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

1
Vitamin D supplementation
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Generally Consistent | 3 studies
2
Insulin therapy
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies
3
Standard care with capillary blood glucose monitoring
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 32 supporting studies and existing graph evidence signals.

Limitations

Consistency cannot yet be determined.
Population details are unavailable.

What has the strongest evidence for glycemic control?

evidence strength

Strong Evidence

Hybrid closed-loop system, Continuous glucose monitoring, and Metformin have the strongest available evidence signals in this evidence set.

ConsistencyScore™: Results are consistent across studies.

Evidence caveat: The evidence includes both beneficial and harmful or worsening results.

Ranked evidence signals

1
Hybrid closed-loop system
EvidenceScore™ Strong | EvidenceScore™ 83.6 | moderate positive | ConsistencyScore™ Consistent | 7 studies
2
Continuous glucose monitoring
EvidenceScore™ Strong | EvidenceScore™ 83.4 | moderate positive | ConsistencyScore™ Consistent | 6 studies
3
Metformin
EvidenceScore™ Strong | EvidenceScore™ 83.2 | strong positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations